Filippo Acconcia

Filippo Acconcia

Sep 21, 2017

Group 6 Copy 33
0
    Please wait...

    About This Project

    70% of breast cancers are estrogen receptor α (ERα)-positive. ERα is the antenna that senses the ovarian hormone estrogen (E2) and drives tumour cell proliferation and spreading. 4OH-tamoxifen and faslodex are given to patients to prevent cancer growth and spreading but they possess serious side effects. Thus, additional drugs are needed to fight breast cancer. We will explore existing drugs for the possibility of ‘reuse’ as breast cancer drugs.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Can low carbohydrate ketogenic diets inhibit cancers?

    Insulin is a hormone which supports growth of normal cells, but also of cancers. A very low carbohydrate (VLC...

    Human placentophagy: What is the microbial composition of raw and processed placental tissue?

    Placentophagy is gaining in popularity as supporters of this behavior claim it has the ability to improve lactation...

    What can we do to improve survival in babies with respiratory distress in Bangladesh?

    Respiratory Distress is a treatable disease which kills hundreds of thousands of babies every year. Most of...

    Campaign Ended